Anti-Mouse Osteopontin [Clone 100D3] — HRP
Anti-Mouse Osteopontin [Clone 100D3] — HRP
Product No.: O143
- -
- -
Clone 100D3 Target Osteopontin Formats AvailableView All Product Type Hybridoma Monoclonal Antibody Alternate Names SPP1 Isotype Mouse IgG2c κ Applications ELISA |
- -
- -
Antibody DetailsProduct DetailsReactive Species Human ⋅ Mouse Host Species Mouse Immunogen Recombinant mouse OPN protein
Product Concentration 0.5 mg/ml Formulation This HRP-conjugated antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4, 1% BSA. (Warning: Use of sodium azide as a preservative will inhibit the enzyme activity of horseradish peroxidase) State of Matter Liquid Storage and Handling This horseradish peroxidase conjugated monoclonal antibody is stable when stored at 2-8°C. Do not freeze. Regulatory Status Research Use Only Country of Origin USA Shipping 2 – 8° C Wet Ice Applications and Recommended Usage? Quality Tested by Leinco ELISA Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity 100D3 activity is directed against mouse and human osteopontin, also known as
secreted phosphoprotein 1 (SPP1). Background Osteopontin is a phosphorylated glycoprotein1 that regulates bone formation, bone tissue remodeling, and promotes osteogenic differentiation of mesenchymal stem cells2. Osteopontin also inhibits adipogenic differentiation, can induce angiogenesis, and promotes leukocyte
adhesion. Osteopontin performs its regulatory roles by interacting with integrins to activate
downstream signaling pathways. In cancer, increased levels of osteopontin are associated with
migration, invasion, and poor prognosis. Osteopontin promotes tumor development by activating
the PI3K/pAkt/NF-κB pathway when interacting with the αvβ3 integrin and can promote cancer
invasion when interacting with CD44. Osteopontin is thus a target for the development of cancer
treatments, including transcription and translation inhibitors as well as blockade by
immunotherapy. 100D3 was generated by immunizing C57BL/6 mice with recombinant osteopontin protein1. Mice with the highest osteopontin antibody titer, as determined by ELISA, were selected for spleen cell electro-fusion with SP2/0 myeloma cells. Fused cells were screen by ELISA with osteopontin protein and then by T cell proliferation rescue assay in anti-CD3/CD28/osteopontin- coated plates. 100D3 is a neutralizing antibody that inhibits colonic tumor growth in vivo and increases tumor- specific cytotoxic T lymphocyte effector function1. Antigen Distribution Osteopontin is a secreted protein found in bone that is also expressed
intracellularly in other tissues, including cardiac fibroblasts, dendritic cells, macrophages,
smooth muscle, endothelial cells, kidney, and brain. In cancer, osteopontin can also be expressed
in tumor cells, myeloid cells, and innate lymphoid cells. Additionally, osteopontin is elevated in
human cancer patient peripheral blood. Ligand/Receptor CD44, Integrins (αVβ3)
NCBI Gene Bank ID UniProt.org Research Area Apoptosis . Cell Biology . Immunology . Oncology . Cancer Biomarker . Stem Cells References & Citations1 Klement JD, Poschel DB, Lu C, et al. Cancers (Basel). 13(5):1006. 2021. 2 Xu W, Bi Z, Lu L, et al. Oncol Rep. 54(5):136. 2025. Technical ProtocolsCertificate of Analysis |
Formats Available
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
